FDA OKs two new uses for biologic arthritis drug adalimumab.
View on PubMed
Abstract & Figures
Sorry, we couldn't extract an abstract for this paper.
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Slides referencing similar topics
Introduction to FDA Drug and Biologic Review Process
Ke Liu • Nov 03, 2017
Evaluation of Meeting Content and Characteristics of Applications for New Drug and Biologic Products
Hong H. Vu • Mar 08, 2018
Analysis of sample formulation patents for biologics • Case studies : insulin glarginine and adalimumab • Strategy for Patenting Formulations
Timothy J. Shea • Oct 27, 2017